Cargando…
Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
Cytokeratin 5 is a marker of basal molecular subtypes of muscle‐invasive bladder cancer (MIBC), which correlates with worse overall survival compared to luminal subtypes. Our observations have not confirmed CK5 as a marker of high‐grade (HG) disease in Ta non‐muscle‐invasive bladder cancer (NMIBC)....
Autores principales: | Muilwijk, Tim, Akand, Murat, Van der Aa, Frank, De Coninck, Vincent, Claessens, Marc, Hente, Robert, Eckstein, Markus, Allory, Yves, Libbrecht, Louis, Joniau, Steven, Gevaert, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358875/ https://www.ncbi.nlm.nih.gov/pubmed/34184816 http://dx.doi.org/10.1111/jcmm.16712 |
Ejemplares similares
-
Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer
por: Luo, Hai-Tao, et al.
Publicado: (2017) -
Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer
por: Wang, Chung-Chieh, et al.
Publicado: (2019) -
Cytokeratin 20-positive hepatocellular carcinoma
por: Fanni, D., et al.
Publicado: (2009) -
Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2018) -
Collecting duct renal cell carcinoma: a single centre series and review of the literature
por: Vanderbruggen, Wies, et al.
Publicado: (2022)